Systematic Assessment of Treatment Effectiveness for Long-Term Management of Stable Atrial Tachycardia in Inpatient and Outpatient Environments
SATELLITE
1 other identifier
observational
1,000
1 country
5
Brief Summary
The aim is to analyze long-term outcomes in a multicenter observational registry including patients undergoing atrial tachycardia rhythm control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Typical duration for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 15, 2025
CompletedFirst Posted
Study publicly available on registry
November 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
ExpectedNovember 20, 2025
November 1, 2025
2 years
November 15, 2025
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality, stroke and cardiovascular hospitalization
From AT rhythm control through study completion, an average of 2 years
Study Arms (1)
Patients undergoing atrial tachycardia rhythm control
Patients undergoing catheter ablation and/or electrocardioversion for atrial tachycardia
Eligibility Criteria
Patients undergoing atrial tachycardia rhythm control
You may qualify if:
- Patients undergoing atrial tachycardia rhythm control
You may not qualify if:
- Follow-up \<30 days after atrial tachycardia rhythm control
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Evangelical Hospital Düsseldorflead
- Universitätsklinikum Hamburg-Eppendorfcollaborator
- Staedtisches Klinikum Karlsruhecollaborator
- Münster University Hospital, Germanycollaborator
- Asklepios Klinik St. Georgcollaborator
Study Sites (5)
EVK Düsseldorf
Düsseldorf, Germany
Asklepios Hospital St. Georg
Hamburg, Germany
University Hospital Hamburg-Eppendorf
Hamburg, Germany
Municipal Clinical Center Karlsruhe
Karlsruhe, Germany
University Hospital Münster
Münster, Germany
Related Publications (3)
Jungen C, Akbulak R, Kahle AK, Eickholt C, Schaeffer B, Scherschel K, Dinshaw L, Muenkler P, Schleberger R, Nies M, Gunawardene MA, Klatt N, Hartmann J, Merbold L, Jularic M, Willems S, Meyer C. Outcome after tailored catheter ablation of atrial tachycardia using ultra-high-density mapping. J Cardiovasc Electrophysiol. 2020 Oct;31(10):2645-2652. doi: 10.1111/jce.14703. Epub 2020 Aug 11.
PMID: 32748442BACKGROUNDKahle AK, Jungen C, Scherschel K, Alken FA, Meyer C. Relationship Between Early and Late Recurrences After Catheter Ablation for Atrial Tachycardia in Patients With a History of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2022 Jun;15(6):e010727. doi: 10.1161/CIRCEP.121.010727. Epub 2022 May 27. No abstract available.
PMID: 35622433BACKGROUNDBrachmann J, Lewalter T, Kuck KH, Andresen D, Willems S, Spitzer SG, Straube F, Schumacher B, Eckardt L, Danilovic D, Thomas D, Hochadel M, Senges J. Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry. Eur Heart J. 2017 May 1;38(17):1317-1326. doi: 10.1093/eurheartj/ehx101.
PMID: 28329395BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian Meyer, MD, MA
EVK, Düsseldorf
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Division of Cardiology, Electrophysiology, Angiology, Intensive Care at the EVK Düsseldorf and Principal Investigator
Study Record Dates
First Submitted
November 15, 2025
First Posted
November 20, 2025
Study Start
January 1, 2024
Primary Completion
January 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
November 20, 2025
Record last verified: 2025-11